Malignant Lesions Associated With Dermatomyositis

Curtis, Arthur C.; Blaylock, Hoyt C.; Harrell, E. Richard

doi:10.1001/jama.1952.03680090008004

Cited by 102 publications

(15 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Curtis et al in .discussing the relationship of cancer to dermatomyositis had suggested that tumor catabolic products might serve as an allergen initiating the disease. 51 The findings in our case were consistent with this view. Dermatomyositis may thus represent a relatively rare and generalized manifestation of a more common sensitivity reaction in malignant tumors.…”

Section: Alterations Of Immunologic Responsiveness In Cancer Patientssupporting

confidence: 92%

Clinical Aspects of Immunity in Untreated Cancer*

Grace

1964

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

Immunologic aspects of cancer have intrigued investigators for a long time. Much of the early enthusiasm for immunological control of cancer stemmed from laboratory experiments using transplantable tumors in animals. Unfortunately, many of these studies used tumors which were genetically foreign to the host and it was later apparent that much of the "cancer immunity" was merely an expression of genetic differences between the transplantable tumors and their hosts. In effect tumors were being used to study homograft responses. Following the advent of highly inbred strains of mice, it was possible to carry out such research with transplantable tumors in carefully controlled genetic systems. More recently spontaneous, carcinogen and virus-induced tumors have been widely studied. The voluminous literature which accumulated has been the subject of a number of excellent reviews among which those of Woglom, Hauschka, Snell and Gorer present distinctive viewpoints.'"' Much has been learned of the genetic and immunologic factors involved in -tumor transplant rejection. Variable degrees of resistance against transplantable tumors in animals may be obtained by active and passive immunization procedures. In some experimental systems involving genetically compatible host and tumors (as well as in certain carcinogen and virus-induced tumors) there is conclusive evidence that tumor specific antigens exist and that immunological reactions can alter the growth of such tumors. Among the many reports concerned with these studies are those of Amos et al; Gorer et al; Prehn, Habel, Sjogren et al; Sachs, Hirsch, Klein et al; Mirand and Grace."13At the clinical level there is evidence that "host factors" are associated with the development and progress of human malignant disease. Unfortunately most of this evidence is indirect, the mechanisms involved are poorly understood, and the role of immunological responses is obscure. The existence of "resistance" factors is suggested by such observations as (1) rare but authenticated cases of spontaneous regression of established tumors;'* (2) prolonged survival of patients after incomplete removal of their c a n~e r ;~~J~ (3) sudden appearance of widespread metastases many years after apparently successful treatment of the primary le~ion;'~JB (4) occasional regression of metastases after treatment of the primary tumor;14J6 ( 5 ) evidence that enormous numbers of the tumor cells are exfoliated into the blood stream and lymphatics without the development of a comparable number of ( 6 ) histological evidence of increased activity (histiocytic, lymphocytic and plasmacytic) in the area of some tumors and in the regional lymph nodes;21*22 (7) the appearance of antibodies against some components or products of their tumors in the serum of a few ~a t i e n t s ;~~ (8) the development of hypersensitivity by certain patients to some components or products of their t~m o r s ;~~~~ (9) demonstrable changes in immunological responsiveness paralleling exacerbations and remissions of certain malignant diseas...

show abstract

Section: Alterations Of Immunologic Responsiveness In Cancer Patientssupporting

confidence: 92%

Clinical Aspects of Immunity in Untreated Cancer*

Grace

1964

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

show abstract

“…Curtis (1952) suggested that tumour catabolic products may serve as allergen initiating the disease, and with Heckeman and Wheeler (1961) demonstrated skin-sensitising antibody to tumour extract in a patient with dermatomyositis and metastatic carcinoma of the lung from the sigmoid colon. Similar results had previously been obtained by Grace and Dao (1959) in a patient with carcinoma of breast, and they too postulated that sensitivity played a role in the genesis of dermatomyositis.…”

Section: Commentmentioning

confidence: 99%

Dermatomyositis following Treatment of Cancer

Calvert

Neale

1965

Postgraduate Medical Journal

View full text Add to dashboard Cite

“…There is also a high incidence of malignant disease, including gastro-intestinal cancer, in this condition; the relationship is so constant that a continuing search for malignancy is indicated in every patient with dermatomyositis (Curtis, Blaylock and Harrell, 1952;Dowling, '955).…”

Section: Alimentary Involvement In Systemic Diseasementioning

confidence: 99%

Alimentary Granulomata and the Immune Response

Slaney

1961

Postgraduate Medical Journal

View full text Add to dashboard Cite

Malignant Lesions Associated With Dermatomyositis

Cited by 102 publications

References 0 publications

Clinical Aspects of Immunity in Untreated Cancer*

Clinical Aspects of Immunity in Untreated Cancer*

Dermatomyositis following Treatment of Cancer

Alimentary Granulomata and the Immune Response

Contact Info

Product

Resources

About